Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen Completed Phase 4 Trials for Invasive Meningococcal Disease Prevention

Indications	Status	Purpose	Phase
DBCOND0047555 (Invasive Meningococcal Disease)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT03694405	Adolescent MenACWY Booster Study	Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine (DB10061) Meningococcal polysaccharide vaccine group A (DB13889) Meningococcal polysaccharide vaccine group C (DB13890) Meningococcal polysaccharide vaccine group W-135 (DB13887) Meningococcal polysaccharide vaccine group Y (DB13888) Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (DB10798) Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (DB10799) Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (DB10801) Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (DB10800)